| CXSL2400436 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-07-09 | | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | | | view |
| CXSL2200411 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2022-08-29 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CXSL2300515 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2023-07-26 | | Jilin Huisheng Biopharmaceutical Co Ltd | | | view |
| CXSL2400772 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-11-13 | | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | | | view |
| JYSB2400021 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products | Supplementary Application | 2024-02-01 | | | | | view |
| JYSB2400035 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products(3.1) | Supplementary Application | 2024-02-27 | | Novo Nordisk A/S | | | view |
| CXSL2300092 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2023-02-08 | | Federal Biotechnology (Zhuhai Hengqin) Co Ltd | | | view |
| CXSL2400105 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-02-07 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2300007 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products | Supplementary Application | 2023-01-11 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| JXSS2000037 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products(3.1) | Import Drug Application | 2020-09-30 | 诺和诺德（中国）制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2021-08-27 | view |
| CXSL2400082 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-02-01 | | | | | view |
| JXSS2000036 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products(3.1) | Import Drug Application | 2020-09-30 | 诺和诺德（中国）制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2021-10-28 | view |
| JXSL1400054 | 德谷胰岛素/利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products | Import Drug Application | 2014-12-11 | 诺和诺德（中国）制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2016-06-20 | view |
| JYSB2100076 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | Supplementary Application | 2021-03-20 | 诺和诺德（中国）制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | In Review | 2021-03-19 | view |
| JYSB1900059 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | Supplementary Application | 2019-02-27 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2019-03-13 | view |
| JYSB1600073 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | Supplementary Application | 2016-05-10 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2017-01-12 | view |
| JYSB1700197 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | Supplementary Application | 2017-11-17 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2017-12-21 | view |
| JXSL1200033 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | Import Drug Application | 2012-04-28 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2014-10-24 | view |
| CXSL2000258 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2020-09-08 | 北京诺博特生物科技有限公司 | Beijing Novotel Biotechnology Co Ltd | In Review | 2020-09-08 | view |
| CXSL1700215 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products(7) | New Drug Application | 2018-03-21 | 北京亦庄国际蛋白药物技术有限公司 | Etinpro (Beijing) Co Ltd | In Review | 2018-03-15 | view |
